Abstract
The human polyomavirus, JCV, is the etiologic agent of a fatal central nervous system (CNS) demyelinating disease known as progressive multifocal leukoencephalopathy (PML). PML occurs predominantly in immunosuppressed patients and remains an intractable complication in AIDS. To date, there are no effective therapies to treat PML. We previously demonstrated that the neuroleptic drug, chlorpromazine, inhibits the endocytic pathway used by JCV to infect glial cells. In this paper, we demonstrate that nontoxic doses of chlorpromazine are effective at inhibiting JCV multiplication and spread in a tissue culture model. The clinical efficacy of this drug or related compounds in treating PML has not been evaluated
Similar content being viewed by others
References
Anden NE, Butcher SG, Corrodi H, Fuxe K, Ungerstedt U (1970). Receptor activity and turnover of dopamine and noradrenaline after neuroleptics. Eur J Pharmacol 11(3): 303–314.
Atwood WJ, Wang L, Durham LC, Amemiya K, Traub RG, Major EO (1995). Evaluation of the role of cytokine activation in the multiplication of JC virus (JCV) in human fetal glial cells. J NeuroVirol 1: 40–49.
Bishop NE (1998). Examination of potential inhibitors of hepatitis A virus uncoating. Intervirology 41(6): 261–271.
Candurra NA, Maskin L, Damonte EB (1996). Inhibition of arenavirus multiplication in vitro by phenothiazines. Antiviral Res 31(3): 149–158.
Harlow E, Lane D (1988). Antibodies: A laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, p.
Hewlett I, Lee S, Molnar J, Foldeak S, Pine PS, Weaver JL, Aszalos A (1997). Inhibition of HIV infection of H9 cells by chlorpromazine derivatives. J Acquir Immune Defic Syndr Hum Retrovirol 15: 16–20.
Hirai H, Takeda S, Natori S, Sekimizu K (1993). Inhibition of SV40 DNA replication in vitro by chlorpromazine. Biol Pharm Bull 16: 565–567.
Hunt RC, Marshall-Carlson L. (1986). Internalization and recycling of transferrin and its receptor: effect of trifluoperazine on recycling in human erythroleukemic cells. J Biol Chem 261: 3681–3686.
Liu CK, Wei G, Atwood WJ (1998). Infection of glial cells by the human polyomavirus JC is mediated by an N-linked glycoprotein containing terminal alpha 2–6 linked sialic acids. J Virol 72: 4643–4649.
Major EO, Miller AE, Mourrain P, Traub RG, de Widt E, Sever J (1985). Establishment of a line of human fetal glial cells that supports JC virus multiplication. Proc Natl Acad Sci USA 82: 1257–1261.
Pho MT, Ashok A, Atwood WJ (2000). JC Virus enters human glial cells by clathrin dependent receptor mediated endocytosis. J Virol 74(5): 2288–2292.
Vacante DA, Traub R, Major EO (1989). Extension of JC virus host range to monkey cells by insertion of a simian virus 40 enhancer into the JC virus regulatory region. Virology 170: 353–361.
Wang LH, Rothberg KG, Anderson RGW (1993). Misassembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation. J Cell Biol 123: 107–117.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Atwood, W.J. A combination of low-dose chlorpromazine and neutralizing antibodies inhibits the spread of JC virus (JCV) in a tissue culture model: Implications for prophylactic and therapeutic treatment of progressive multifocal leukencephalopathy. Journal of NeuroVirology 7, 307–310 (2001). https://doi.org/10.1080/13550280152537157
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1080/13550280152537157